Skip to main content
. 2022 Dec 15;10(12):3261. doi: 10.3390/biomedicines10123261

Figure 1.

Figure 1

Evaluation of the SARS-CoV-2-specific humoral response in eight people living with HIV (PLWH) up to 2 months after the fourth vaccine dose. Anti-S IgM (cut off = 1) (A), anti-S IgG (cut off = 87.8) (B), neutralizing IgG (cut off = 1) (C), and anti-RBD IgG (cut off = 130) (D) serum levels were evaluated in PLWH before, one week, one month and two months after the fourth vaccine dose. Each color corresponds to a different subject. Black dots indicate mean values. * p ≤ 0.05, ** p ≤ 0.005. Error bars indicate SE values.